Barrington Health News (Rhode Island, United States)

Unetixs will incorporate Endothelix's VENDYS technology into its peripheral vascular diagnostic systems. The alliance will extend availability of Endothelix’s noninvasive cardiovascular diagnostics throughout Unetixs’ US & internatioinal markets.

Five-minute test on highly accurate, affordable Revo® 1100 peripheral vascular diagnostic system enables primary physicians, podiatrists and cardiologists to quickly diagnose peripheral arterial disease.